For this purpose the human breast cancer model MDA-MB-231 was chosen for its aggressive properties and expression of CCR7 as shown in Supplementary Figure 2 as compared to the non-aggressive MCF-7 breast cancer cell line. This evidence concerns the gene CCR7 and breast carcinoma.